Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative Care

Psilocybin-assisted therapy (PAT) has gained recognition as an innovative intervention in hospice and palliative care, demonstrating potential in mitigating the psychological, spiritual, and existential distress experienced by patients with serious illnesses. This article explores the role of PAT within these care settings, emphasizing its influence on various dimensions of human suffering, as supported by recent research and the Theory of Self-Transcendence. Administered in a controlled environment, psilocybin facilitates transformative experiences, contributing to anxiety reduction and fostering acceptance of mortality. Studies suggest that these therapeutic effects are closely linked to mystical experiences induced by the substance, which enhance one’s sense of connection and meaning. Furthermore, the Theory of Self-Transcendence provides a conceptual model for understanding how PAT can support personal development and well-being, even in contexts of vulnerability. It underscores that wellbecoming extends beyond merely alleviating suffering, representing an evolving process of transformation and acceptance. Despite its promise, PAT’s clinical application remains constrained by ethical, regulatory, and cultural challenges. Addressing these obstacles necessitates collaborative initiatives, specialized training for professionals, and expanded research efforts to develop standardized, safe, and effective protocols. Ultimately, PAT emerges as a valuable therapeutic approach capable of bridging science and spirituality to enhance patients’ quality of life during periods of profound vulnerability. By integrating this modality, hospice and palliative care can extend their scope beyond traditional biomedical treatments, offering relief from suffering in the context of serious and terminal illnesses.